Phentermine and Fenfluramine: Preclinical Studies in Animal Models of Cocaine Addiction
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Combined dopamine (DA) and 5‐hydroxytryptamine (5‐HT) releasers such as phentermine (PHEN) and fenfluramine (FEN) are reported, in open label studies, to reduce craving for alcohol and cocaine and to prevent relapse. The objective of the studies reported here was to assess the actions of these agents alone and in combination in various animal models of drug addiction. Study 1. in vivo microdialysis experiments demonstrate that these agents preferentially release mesolimbic DA (PHEN) and 5‐HT (FEN). Patients who relapse and use cocaine while taking these medications report diminished cocaine‐like subjective effects. Microdialysis experiments were performed in awake rats, and dialysate samples were analyzed for DA and 5‐HT. PHEN (1 mg/kg, intravenously (i.v.)) elevated DA (2–3‐fold) for over 1.5 hr. Administration of cocaine (3 mg/kg, i.v.) increased DA 6‐fold in saline‐treated rats, but only 3‐fold in PHEN‐treated rats. PHEN did not reduce cocaine‐induced increases in 5‐HT. Study 2. These agents were assessed in a mouse model of cocaine‐conditioned motoric activity (CCMA). Pretreatment with non‐activating doses of PHEN (4.6 mg/kg, intraperitoneally (i.p.)) enhanced CCMA, whereas non‐depressing doses of FEN (0.1 mg/kg, i.p.) did not alter CCMA or the PHEN‐induced increase in CCMA. In contrast, sub‐effective doses of FEN reduced CCMA stereotypy‐like locomotion, whereas sub‐effective doses of PHEN were without effect. PHEN reversed the FEN‐induced increase in CCMA stereotypy‐like locomotion. Study 3. PHEN and FEN were assessed in the conditioned place preference model. FEN produced marked aversions for an environment previously associated with its administration and the minimum dose producing this effect was 3.0 mg/kg. In contrast, administration of PHEN, amphetamine (1.0–3.0 mg/kg) or morphine (3.0–5.0 mg/kg) produced dose‐related preferences for the drug‐paired place. However, the magnitude of the response to PHEN was less than that produced by the other prototypic drugs of abuse. In rats that received FEN (0.3 or 3.0 mg/kg) in combination with PHEN (3.0 mg/kg), the conditioned rewarding effects of PHEN were abolished. These data demonstrate that the rewarding effects of PHEN can be conditioned to stimuli previously associated with its administration. However, the conditioned response to this agent is less then that produced by prototypic drugs of abuse. The finding that PHEN‐induced place preferences were attenuated by doses of FEN demonstrates that the combination of FEN/PHEN is devoid of motivational effects. The preclinical data obtained with PHEN/FEN in various models of drug provide a strong rationale for pursuing controlled clinical trials in humans with agents that act via a similar mechanism of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
Baxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293
New concepts in cocaine addiction: The dopamine depletion hypothesis
Dackis, C. A., & Gold, M. S. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90022-3 · Cited by 607
HOEBEL, B. G., HERNANDEZ, L., SCHWARTZ, D. H., MARK, G. P., & HUNTER, G. A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb53242.x · Cited by 220
Cited by
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
The dopamine motive system: implications for drug and food addiction
Volkow, N. D., Wise, R. A., & Baler, R. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.130 · Cited by 939
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Self-citationMonoamine transporters and psychostimulant drugs
Rothman, R. B., & Baumann, M. H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.054 · Cited by 502
Self-citationDysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm
Meyer, J. H., McMain, S., Kennedy, S. H., Korman, L., Brown, G. M., DaSilva, J. N., Wilson, A. A., Blak, T., Eynan-Harvey, R., Goulding, V. S., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.90 · Cited by 264
Metadata
- Authors
- ROTHMAN, R. B., ELMER, G. I., SHIPPENBERG, T. S., REA, W., & BAUMANN, M. H.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 1998-05
- Volume
- 844
- Issue
- 1
- Pages
- 59-74
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2008344720
- Cited by
- 49
- References
- 4
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phentermine and Fenfluramine: Preclinical Studies in Animal Models of Cocaine Addiction. https://app.cochat.ai/papers/10.1111/j.1749-6632.1998.tb08222.x
- The paper
- ROTHMAN, R. B., ELMER, G. I., SHIPPENBERG, T. S., REA, W., & BAUMANN, M. H. (1998). Phentermine and Fenfluramine: Preclinical Studies in Animal Models of Cocaine Addiction. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1998.tb08222.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.